Abstract:The constrained dipeptide surrogates 5- and 7-hydroxy indolizidin-2-one N-(Boc)amino acids have been synthesized from L-serine as a chiral educt. A linear precursor ∆4-unsaturated (2S,8S)-2,8-bis[N-(Boc)amino]azelic acid was prepared in five steps from L-serine. Although epoxidation and dihydroxylation pathways gave mixtures of hydroxy indolizidin-2-one diastereomers, iodolactonization of the ∆4-azelate stereoselectively delivered a lactone iodide from which separable (5S)- and (7S)-hydroxy indolizidin-2-one N… Show more
“…The syntheses of mimics 19 and (6 S ,7 S )‐ 8 were respectively achieved using a common approach from the respective carboxylic acids 15 and 16 , which were synthesized according to the protocols described in reference 26 (Scheme 1). Initially, acids 15 and 16 were respectively coupled to (2 S )‐3‐pyridylalaninyl‐(3 S )‐β‐homophenylalanine benzyl ester ( 20 ) 11,12 using TBTU and HOBt to obtain the respective peptides 21 and 22 in 60% and 55% yields.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, effective syntheses of (3 S ,5 S ,6 S ,9 S )‐Boc‐(5‐hydroxy)I 2 aa‐OH ( 15 ) and (3 S ,6 S ,7 S ,9 S )‐Boc‐(7‐hydroxy)I 2 aa‐OH [ 16 , Figure 3] were achieved by a route involving the construction of a ∆ 4 –2,8‐diaminoazelate via a copper catalyzed double S N 2′ addition of zincates derived from methyl β‐iodo alaninate onto ( E )‐1,3‐dichloroprop‐1‐ene, followed by stereoselective ring closures employing a facial selective iodolactonization 26 . The crystal structure of (3 S ,6 S ,7 S ,9 S )‐Boc‐(7‐hydroxy)I 2 aa‐OMe ( 17 ) revealed two conformers in the unit cell with respective ψ i + 1 and ϕ i + 2 dihedral angle values (−172° and −78°; −175° and −78°) which were similar to those of the unsubstituted (3 S ,6 S ,9 S )‐Boc‐I 2 aa‐OMe ( 9 : −176° and −78°), the bicycle of which is found in the most potent FP modulator (6 S )‐ 2 .…”
Section: Introductionmentioning
confidence: 99%
“…19 Recently, effective syntheses of (3S,5S,6S,9S)-Boc-(5-hydroxy) I 2 aa-OH (15) and (3S,6S,7S,9S)-Boc-(7-hydroxy)I 2 aa-OH [16,Figure 3] were achieved by a route involving the construction of a Δ 4 -2,8-diaminoazelate via a copper catalyzed double S N 2 0 addition of zincates derived from methyl β-iodo alaninate onto (E)-1,3-dichloroprop-1-ene, followed by stereoselective ring closures employing a facial selective iodolactonization. 26 The crystal structure of (3S,6S,7S,9S)-Boc-(7-hydroxy)I 2 aa-OMe (17) revealed two conformers in the unit cell with respective ψ i + 1 and ϕ i + 2 dihedral angle values (À172 and À78 ; À175 and À78 ) which were similar to those of the unsubstituted (3S,6S,9S)-Boc-I 2 aa-OMe (9: À176 and À78 ), the bicycle of which is found in the most potent FP modulator (6S)-2. Although crystals of analogs of Boc-(5-hydroxy)I 2 aa-OH 15 have yet to be obtained, the related o-NBS-(5-iodo)I 2 aa-OMe (18) has been characterized in the solid state by X-ray and shown to have internal ψ i + 1 and ϕ i + 2 dihedral angle values (À127 and À65 ), 24 The uterus was obtained immediately from CD-1 mice after term delivery under anesthesia (2.5% isoflurane).…”
In pursuit of more effective-labor delaying tocolytic agents, the prostaglandin F2α (PGF2α) receptor (FP) modulator PDC113.824 [(6S)-2] represents a potent lead for developing therapy to treat preterm birth. Derivatives of FP modulator (6S)-2 were synthesized, possessing respectively 5-and 7-hydroxyl groups on the indolizidin-2-one amino acid (I 2 aa) residue. The effects of the alcohol substituents were examined in a PGF2α-induced myometrial contraction assay. Based on knowledge of dihedral angle values of model I 2 aa peptides from X-ray analyses, the results of the study indicate respectively encouraging and limited potential for creating improved tocolytic agents by modifications at the 5-and 7-positions.indolizidin-2-one amino acids, peptidomimetics, preterm birth, prostaglandin-F2α receptor, tocolytic
| INTRODUCTIONPreterm birth (PTB), parturition before 37 weeks of gestation, is associated with high mortality and morbidity rates. 1 An unmet medical urgency, PTB has some of the most expensive healthcare expenditures per patient. [2][3][4] Each year, about 15 million babies are born prematurely globally, resulting in 1.1 million deaths, most of which occur in low-and middle-income countries. 1,5 Tocolytic drugs are currently used to block uterine contractions and delay preterm labor, but have shown marginal efficacy and may cause adverse effects for both the mother and the fetus. 6 Novel therapies to treat
“…The syntheses of mimics 19 and (6 S ,7 S )‐ 8 were respectively achieved using a common approach from the respective carboxylic acids 15 and 16 , which were synthesized according to the protocols described in reference 26 (Scheme 1). Initially, acids 15 and 16 were respectively coupled to (2 S )‐3‐pyridylalaninyl‐(3 S )‐β‐homophenylalanine benzyl ester ( 20 ) 11,12 using TBTU and HOBt to obtain the respective peptides 21 and 22 in 60% and 55% yields.…”
Section: Resultsmentioning
confidence: 99%
“…Recently, effective syntheses of (3 S ,5 S ,6 S ,9 S )‐Boc‐(5‐hydroxy)I 2 aa‐OH ( 15 ) and (3 S ,6 S ,7 S ,9 S )‐Boc‐(7‐hydroxy)I 2 aa‐OH [ 16 , Figure 3] were achieved by a route involving the construction of a ∆ 4 –2,8‐diaminoazelate via a copper catalyzed double S N 2′ addition of zincates derived from methyl β‐iodo alaninate onto ( E )‐1,3‐dichloroprop‐1‐ene, followed by stereoselective ring closures employing a facial selective iodolactonization 26 . The crystal structure of (3 S ,6 S ,7 S ,9 S )‐Boc‐(7‐hydroxy)I 2 aa‐OMe ( 17 ) revealed two conformers in the unit cell with respective ψ i + 1 and ϕ i + 2 dihedral angle values (−172° and −78°; −175° and −78°) which were similar to those of the unsubstituted (3 S ,6 S ,9 S )‐Boc‐I 2 aa‐OMe ( 9 : −176° and −78°), the bicycle of which is found in the most potent FP modulator (6 S )‐ 2 .…”
Section: Introductionmentioning
confidence: 99%
“…19 Recently, effective syntheses of (3S,5S,6S,9S)-Boc-(5-hydroxy) I 2 aa-OH (15) and (3S,6S,7S,9S)-Boc-(7-hydroxy)I 2 aa-OH [16,Figure 3] were achieved by a route involving the construction of a Δ 4 -2,8-diaminoazelate via a copper catalyzed double S N 2 0 addition of zincates derived from methyl β-iodo alaninate onto (E)-1,3-dichloroprop-1-ene, followed by stereoselective ring closures employing a facial selective iodolactonization. 26 The crystal structure of (3S,6S,7S,9S)-Boc-(7-hydroxy)I 2 aa-OMe (17) revealed two conformers in the unit cell with respective ψ i + 1 and ϕ i + 2 dihedral angle values (À172 and À78 ; À175 and À78 ) which were similar to those of the unsubstituted (3S,6S,9S)-Boc-I 2 aa-OMe (9: À176 and À78 ), the bicycle of which is found in the most potent FP modulator (6S)-2. Although crystals of analogs of Boc-(5-hydroxy)I 2 aa-OH 15 have yet to be obtained, the related o-NBS-(5-iodo)I 2 aa-OMe (18) has been characterized in the solid state by X-ray and shown to have internal ψ i + 1 and ϕ i + 2 dihedral angle values (À127 and À65 ), 24 The uterus was obtained immediately from CD-1 mice after term delivery under anesthesia (2.5% isoflurane).…”
In pursuit of more effective-labor delaying tocolytic agents, the prostaglandin F2α (PGF2α) receptor (FP) modulator PDC113.824 [(6S)-2] represents a potent lead for developing therapy to treat preterm birth. Derivatives of FP modulator (6S)-2 were synthesized, possessing respectively 5-and 7-hydroxyl groups on the indolizidin-2-one amino acid (I 2 aa) residue. The effects of the alcohol substituents were examined in a PGF2α-induced myometrial contraction assay. Based on knowledge of dihedral angle values of model I 2 aa peptides from X-ray analyses, the results of the study indicate respectively encouraging and limited potential for creating improved tocolytic agents by modifications at the 5-and 7-positions.indolizidin-2-one amino acids, peptidomimetics, preterm birth, prostaglandin-F2α receptor, tocolytic
| INTRODUCTIONPreterm birth (PTB), parturition before 37 weeks of gestation, is associated with high mortality and morbidity rates. 1 An unmet medical urgency, PTB has some of the most expensive healthcare expenditures per patient. [2][3][4] Each year, about 15 million babies are born prematurely globally, resulting in 1.1 million deaths, most of which occur in low-and middle-income countries. 1,5 Tocolytic drugs are currently used to block uterine contractions and delay preterm labor, but have shown marginal efficacy and may cause adverse effects for both the mother and the fetus. 6 Novel therapies to treat
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.